|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
On Demand
 Learn more
|
|
| Advertisement |
Launching into Value: Pharma’s Quest to Align Drug Prices with Outcomes
On Demand
 Learn more
|
|
|
|
|
ADVERTISEMENT
|
| Calendar |
|
|
/ 14 November: EU GDPR Bootcamp Life Sciences / |
|
London, UK |
|
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences
/ |
|
London, UK |
|
/ November 28–29: Commercial Data Insights / |
|
Philadelphia, PA |
|
/ December 4–5: Connected Devices in Healthcare / |
|
San Diego, CA |
|
/ December 12: Specialty Products Data Strategy Summit / |
|
Philadelphia, PA |
|
/ January 23–24: 13th Biosimilars Summit / |
|
Alexandria, VA |
|
/ January 24–25: Reimbursement and Contracting / |
|
Philadelphia, PA |
|
/ February 7–8, 2018: Speaker Programs 2018 / |
|
Philadelphia, PA |
|
/ March 25–28, 2018: 14th Annual Pharma Forum / |
|
Philadelphia, PA |
|
|
|
| Advertisement |
 |
|
|
| Industry update |
| //Astellas (Northbrook, IL) promoted Nate Crisel to vice president, Real World Informatics & Analytics and Gary Thal, M.D., to vice president, Specialty, Medical Affairs, Americas. //Tenaya Therapeutics (South San Francisco, CA) appointed Tim Hoey, Ph.D. as chief scientific officer. //H. Lundbeck A/S (Copenhagen, Denmark) announced that chief financial officer Anders Götzsche will serve as interim chief executive officer while the company looks for a replacement for Kåre Schultz, who left the company on October 31 to become CEO at Teva Pharmaceuticals. //Castle Creek Pharmaceuticals, appointed Amir Tavakkol, Ph.D., as executive vice president and chief development officer. |
|
|
